Primary angiitis of the CNS and ANCA-associated vasculitis: from pathology to treatment

被引:3
|
作者
Sherri, Alaa [1 ]
Mortada, Mohamad Mahdi [2 ]
Makowska, Joanna [1 ]
Lewandowska-Polak, Anna [1 ]
机构
[1] Med Univ Lodz, Dept Rheumatol, Lodz, Poland
[2] Med Univ Lodz, Dept Immunol & Allergy, Lodz, Poland
关键词
Primary angiitis of the central nervous system (PACNS); ANCA-associated vasculitis (AAV) with central nervous system involvement; Vasculitis of the central nervous system (CNS); Diagnostic workup and treatment; CENTRAL-NERVOUS-SYSTEM; INVOLVEMENT; GRANULOMATOSIS; POLYANGIITIS; MANIFESTATIONS; DIAGNOSIS; COHORT; MRI; RITUXIMAB; PATTERNS;
D O I
10.1007/s00296-023-05461-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasculitis of the central nervous system can be a localized process, such as primary angiitis of the central nervous system (PACNS), or systemic vasculitis, such as ANCA-associated vasculitis (AAV). Since both conditions share neurological manifestations, the following review will discuss the neurological aspects of both. This review aims to provide a comprehensive comparison of the pathogenesis, clinical manifestation and assessment, diagnostic workup, and treatment protocol for both PACNS and AAV with central nervous system involvement. To provide a comprehensive comparison and update, a literature review was conducted using PubMed and Ovid databases (Embase and Medline). Then, the references were retrieved, screened, and selected according to the inclusion and exclusion criteria. PACNS and AAV share similarities in clinical presentation and neurological symptoms, especially in terms of headache, focal deficits, and cognitive impairment. Additionally, both conditions may exhibit similarities in laboratory and radiological findings, making brain biopsy the gold standard for differentiation between the two conditions. Moreover, the treatment protocols for PACNS and AAV are nearly identical. Comparing PACNS and AAV with CNS involvement highlights the similarities in clinical presentation, radiological findings, and treatment protocols between the two conditions. Further research should focus on establishing a practical diagnostic protocol.
引用
收藏
页码:211 / 222
页数:12
相关论文
共 50 条
  • [1] Primary angiitis of the CNS and ANCA-associated vasculitis: from pathology to treatment
    Alaa Sherri
    Mohamad Mahdi Mortada
    Joanna Makowska
    Anna Lewandowska-Polak
    Rheumatology International, 2024, 44 : 211 - 222
  • [2] Treatment Strategies in ANCA-Associated Vasculitis
    Emejuaiwe, Nkechinyere
    CURRENT RHEUMATOLOGY REPORTS, 2019, 21 (07)
  • [3] Avacopan in the treatment of ANCA-associated vasculitis
    Tesar, Vladimir
    Hruskova, Zdenka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (05) : 491 - 496
  • [4] Comorbidities in ANCA-associated vasculitis
    Kronbichler, Andreas
    Leierer, Johannes
    Gauckler, Philipp
    Shin, Jae Il
    RHEUMATOLOGY, 2020, 59 : 79 - 83
  • [5] ANCA-associated vasculitis
    Yates, Max
    Watts, Richard
    CLINICAL MEDICINE, 2017, 17 (01) : 60 - 64
  • [6] ANCA-associated vasculitis-treatment standard
    Chalkia, Aglaia
    Jayne, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (06) : 944 - 955
  • [7] Present and future of ANCA-associated vasculitis
    Jayne, D.
    REVUE DE MEDECINE INTERNE, 2017, 38 : A10 - A12
  • [8] Avacopan for the treatment of ANCA-associated vasculitis
    Osman, Mohammed
    Cohen Tervaert, Jan Willem
    Pagnoux, Christian
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (07) : 717 - 726
  • [9] Treatment of Relapses in ANCA-Associated Vasculitis
    McClure, Mark
    Jones, Rachel B.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (07): : 967 - 969
  • [10] Obinutuzumab as treatment for ANCA-associated vasculitis
    Amudala, Naomi A.
    Boukhlal, Sara
    Sheridan, Brittany
    Langford, Carol A.
    Geara, Abdallah
    Merkel, Peter A.
    Cornec, Divi
    RHEUMATOLOGY, 2022, 61 (09) : 3814 - 3817